Catalyst Wire Dossier Catalyst Wire Dossier

Ambrx growth hormone deficiency compound

· Ambrx, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ambrx growth hormone deficiency compound, covering 2009-10-12 to 2009-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD). [Phase 2]

See pricing